A Comparison of tumor demarcation potential for various hematoporphyrin derivatives and phtalocyanine using laser-induced fluorescence [PDF]
, 1988 Laser-induced fluorescence data for rats injected with the different tumor-marking drugs, dihematoporphyrin ether, poly hematoporphyrin esters, hematoporphyrin and phtalocyanine, are presented.
S Andersson-Engels +14 more
core +1 more source
In vitro characterization of monoaspartyl chlorin e\u3csub\u3e6\u3c/sub\u3e and diaspartyl chlorin e\u3csub\u3e6\u3c/sub\u3e for photodynamic therapy [PDF]
, 1988 The characteristics of two new chlorin photosensitizers were studied in cell culture by determining phototoxicity, subcellular localization, and photophysical properties.
Roberts, W. Gregory +4 more
core +1 more source
Photodynamic methods for fluorescence diagnosis and therapy of photosensitized tumors. [PDF]
, 1992 Several substances, e.g., hematoporphyrin derivatives (HpD), dihematoporphyrin ether/ester (DHE), phthalocyanines, porphycenes, and other drugs are known to be temporarily and selectively stored in tumors after systematic application.
Unsoeld, E., Eberhard Unsoeld
core +1 more source
Photodynamic therapy: A promising new modality for the treatment of cancer [PDF]
, 1996 The first reports on photodynamic therapy (PDT) date back to the 1970s. Since then, several thousands of patients, both with early stage and advanced stage solid tumours, have been treated with PDT and many claims have been made regarding its efficacy ...
J.J. Schuitmaker +17 more
core +1 more source
Differential effect of Photofrin II on growth of human smooth muscle cells from nonatherosclerotic arteries and atheromatous plaques in vitro. [PDF]
, 1990 The effect of dihematoporphyrin-ester or -ether (DHE), a photosensitizing porphyrin with different amounts of aggregates, on the growth of cultured smooth muscle cells obtained from nonatherosclerotic arteries and from atheromatous plaques (primary ...
P C Dartsch, E Betz, T Ischinger
core +1 more source
Photodynamic therapy for endobronchial malignant disease: A prospective fourteen-year study [PDF]
, 1997 Background: After intravenous injection, the photosensitizer dihematoporphyrin ether is selectively retained in tumor cells. This photosensitizer absorbs 630 nm wavelength light energy and produces a singlet oxygen that destroys the tumor.
McCaughan, James S., Williams, Thomas E.
core +1 more source
Effect of low energy argon laser and dihematoporphyrin ether on the growth, viability, and catecholamine production of C1300 murine neuroblastoma cells in vitro [PDF]
, 1988 Low power laser induced fluorescence of dihematoporphyrin ether (DHE, photofrin 2) is used to detect cancer. The goal was to determine the effect of low power argon laser light and DHE on C-1300 murine neuroblastoma cells (MNB, NB41A3).
Rogers, David William
core +1 more source
Результаты III фазы клинических исследований препарата радахлорин для фотодинамической терапии предрака и начального рака шейки матки [PDF]
, 2015 The results of clinical study for efficacy of photodynamic therapy (PDT) with radachlorine in patients with pre-cancer and cancer of cervix are represented.
L. G. Serova +5 more
core +2 more sources
Humatopoietic effects of photofrin [PDF]
, 1996 In the presence of visible light, certain naturally-occurring and synthetic non-metallic porphyrins and their derivatives can cause toxic effects within cells.
Hunt, David William Carey
core
Statistics of Photon Paths in Tissue During Diffuse Reflectance Spectroscopy [PDF]
, 1991 The rapid development of the use of lasers in therapeutic and diagnostic medicine in the past few years has generated interest in measuring the optical properties of tissue.
Osei, Ernest Kwaku
core